Return to search results
Bivalirudin
Bivalirudin is an injectable anticoagulant medication administered intravenously to prevent blood clots during procedures like angioplasty. It acts as a direct thrombin inhibitor, helping to reduce the risk of clotting in patients with certain heart conditions. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Bivalirudin is an injectable anticoagulant medication administered intravenously to prevent blood clots during procedures like angioplasty. It acts as a direct thrombin inhibitor, helping to reduce the risk of clotting in patients with certain heart conditions. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Bivalirudin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Bivalirudin — ANDA 202471 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202471"
}
]
|
| identifier | ANDA202471 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"fda",
"health-care",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Bivalirudin |
